Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

January

15
2025

Sensus Healthcare Reports First Quarter 2025 Financial Results

21 SRT systems shipped during the quarter; revenues of $8.3…

January

24
2019

Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiation Therapy System

Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA…

January

24
2019

Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiation Therapy System

Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA…

January

23
2019

Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study…

January

23
2019

Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study…